sinecatechins 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4785	84650-60-2

Description:

Molecule

Description

Synonyms:

sinecatechins
kunecatechins

Molecular weight: 1497.29
Formula: C74H64O34
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 197.37
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
Oct. 31, 2006	FDA	MEDIGENE AG

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	D06BB12	DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE Antivirals

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Condyloma acuminatum	indication	240542006	DOID:11168
Perianal warts	indication	266114001

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Patent number	Patent expiration date	Patent use
15%	VEREGEN	ANI PHARMS	N021902	Oct. 31, 2006	RX	OINTMENT	TOPICAL	10434059	Nov. 18, 2022	TREATMENT OF GENITAL WARTS
15%	VEREGEN	ANI PHARMS	N021902	Oct. 31, 2006	RX	OINTMENT	TOPICAL	9770406	July 12, 2025	TREATMENT OF GENITAL WARTS
15%	VEREGEN	ANI PHARMS	N021902	Oct. 31, 2006	RX	OINTMENT	TOPICAL	7858662	Oct. 2, 2026	TREATMENT OF GENITAL WARTS

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
T432289GYZ	UNII
D08997	KEGG_DRUG
4027570	VUID
N0000176157	NUI
4025783	VANDF
4027570	VANDF
C1960121	UMLSCUI
CHEMBL1201723	ChEMBL_ID
DB01266	DRUGBANK_ID
753346	RXNORM
22615	MMSL
24912	MMSL
012477	NDDF
426809000	SNOMEDCT_US
188265-33-0	SECONDARY_CAS_RN

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Veregen	HUMAN PRESCRIPTION DRUG LABEL	1	10337-450	OINTMENT	150 mg	TOPICAL	NDA	25 sections